Bristol-Myers Squibb Studying Impact of Cancer Survivorship

Bristol-Myers Squibb is committed to studying the impact on survivorship throughout the continuum of cancer care with the goal improving communication between patients and their care teams about quality of survival in cancer.

Research on the survivorship concept shows us that this is a growing concern, but there is a lack of a standardized definition and appropriate measures to evaluate the quality of survivorship, resulting in a new need for and focus on care beyond diagnosis and treatment.

Click here to learn more about cancer survivorship